High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses

Background: Early evidence suggested that the impact of the COVID-19 pandemic was less severe in Africa compared to other parts of the world. However, more recent studies indicate higher SARS-CoV-2 infection and COVID-19 mortality rates on the continent than previously documented. Research is needed...

Full description

Bibliographic Details
Main Authors: Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, Sarah John-Olabode, Iorhen E. Akase, Augustina Nwosu, Donald J. Hamel, Charlotte A. Chang, Phyllis J. Kanki
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Journal of Clinical Virology Plus
Subjects:
COVID-19
SARS CoV-2
Healthcare workers
Vaccine
Antibody
T-cell
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038023000236

Internet

http://www.sciencedirect.com/science/article/pii/S2667038023000236

Similar Items